Related Experiment Video
Updated: Nov 9, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Systematic Review of Minimally Invasive Surgery for Mitral Valve Infective Endocarditis
Emily Shih1,2, John J Squiers1,2, J Michael DiMaio1,3
1570470 Baylor Scott & White Research Institute, The Heart Hospital Baylor Plano, Plano, TX, USA.
Objective:
The scope of application of minimally invasive mitral valve surgery is expanding. However, the safety and efficacy of minimally invasive mitral valve surgery in the setting of infective endocarditis is not well known. We sought to identify the best evidence available to support a minimally invasive surgical approach for mitral valve infective endocarditis.
Methods:
A systematic review of minimally invasive mitral valve surgery for infective endocarditis was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
Results:
A total of 6 manuscripts describing 271 patients were identified. Mean age was 60.4 ± 14.9 years old, and 60.1% patients were male. Mean EuroSCORE II was 24.6 ± 23.2. Mitral valve repair was achieved in 32.4% of cases. The average in-hospital mortality was 9.4%, and average length of hospital stay was 21.6 days. Survival was 89.1% at 30 days, and 1-year survival was 79.3%. Rate of conversion to sternotomy was 1.8%. Postoperative complications included: 6.9% postoperative bleeding, 9.3% new postoperative dialysis, 2.3% postoperative stroke, and 3.4% recurrence of endocarditis. Reoperation over the long-term was required in 9.3% of cases.
Conclusions:
Minimally invasive mitral valve surgery for infective endocarditis has acceptable perioperative morbidity as well as short- and intermediate-term mortality at experienced centers. Minimally invasive mitral valve surgery may be an acceptable alternative approach to infective endocarditis and warrants further study.
Insights
Minimally invasive mitral valve surgery for infective endocarditis shows acceptable short-term outcomes. This approach may be a viable alternative, though further research is recommended.
Area of Science:
- Cardiac Surgery
- Infective Endocarditis
- Minimally Invasive Procedures
Background:
- The application of minimally invasive mitral valve surgery is expanding.
- Data on the safety and efficacy of minimally invasive mitral valve surgery for infective endocarditis is limited.
Purpose of the Study:
- To identify the best available evidence supporting a minimally invasive surgical approach for mitral valve infective endocarditis.
Main Methods:
- A systematic review was conducted following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.
- Included studies focused on minimally invasive mitral valve surgery for infective endocarditis.
Main Results:
- Six manuscripts reported on 271 patients; mean age 60.4 years, 60.1% male.
- Average in-hospital mortality was 9.4%, 30-day survival 89.1%, 1-year survival 79.3%.
- Conversion to sternotomy was 1.8%; reoperation was required in 9.3%.
Conclusions:
- Minimally invasive mitral valve surgery for infective endocarditis demonstrates acceptable perioperative morbidity and mortality at experienced centers.
- This approach may be a suitable alternative for infective endocarditis, warranting further investigation.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Endocarditis I: Introduction

